Sort   by:  
 Page size 
ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma
Bidirectional communication between tumors and neurons has emerged as a key facet of the tumor microenvironment that drives malignancy. Another hallmark feature of cancer is epigenomic dysregulation, where alterations in gene expression influences cell states and interactions with the tumor microenv...
ORGANISM(S): Mus musculus (Mouse) 
2024-09-09 | PXD048170 | Pride
Extensive Vascular Remodeling Without Widespread Blood-Brain Barrier Disruption in a Murine Model of ZFTA-RELA Ependymoma
Over 60% of supratentorial (ST) ependymomas harbor a ZFTA-RELA (ZRfus) gene fusion (formerly C11orf95-RELA). To study the biology of ZRfus, we developed an autochthonous mouse tumor model using in utero electroporation (IUE) of the embryonic mouse brain. Integrative epigenomic and transcriptomic map...
ORGANISM(S): Mus musculus 
2021-03-29 | GSE161679 | GEO
To profile H3K4me3Q5Ser (5HT-H3) distribution in mouse ZFTA-RELA ependymoma tumors Furthermore, we also sought to examine H3K27ac and H3K27me3 distribution in mouse ZFTA-RELA ependymoma versus ETV5 overexpressing tumors
ORGANISM(S): Mus musculus 
2024-06-03 | GSE246032 | GEO
To profile gene expression differences between mouse non-tumor cortex versus ZFTA-RELA ependymoma versus ETV5 overexpressing tumors Furthermore, we also sought to profile gene expression differences between ZFTA-RELA ependymoma versus NPY overexpressing tumor
ORGANISM(S): Mus musculus 
2024-06-03 | GSE246031 | GEO
Background: ZFTA-RELA ependymoma (EPN) is the most common supratentorial pediatric EPN subtype and is associated with poor clinical outcomes. The blood-brain barrier (BBB) is a major obstacle to effective drug delivery into the brain. Brain tumors can exhibit substantial BBB heterogeneity, and the e...
ORGANISM(S): Mus musculus 
2026-07-29 | GSE335316 | GEO
Sort   by:  
 Page size